An extensive database analysis demonstrates significant increase in platelet quantity in unselected hospitalized patients following treatment with oseltamivir

Haematologica. 2024 Jun 1;109(6):1933-1935. doi: 10.3324/haematol.2023.283731.

Authors

Chandrasekar Muthiah¹, Qinghua Lian², Samantha Benz³, Aniko Szabo², Karin Hoffmeister⁴, Juliana Perez Botero⁴, Laura C Michaelis⁵

Affiliations

¹ Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI. cmuthiah@mcw.edu.
² Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI.
³ Department of Internal Medicine, Aurora Health Care, Milwaukee, WI.
⁴ Versiti and Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI.
⁵ Department of Medicine, Division of Hematology/Oncology, Froedtert Hospital/Medical College of Wisconsin, Milwaukee.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Antiviral Agents* / therapeutic use
Blood Platelets* / drug effects
Blood Platelets* / metabolism
COVID-19 Drug Treatment
Databases, Factual
Female
Hospitalization*
Humans
Influenza, Human / blood
Influenza, Human / drug therapy
Male
Middle Aged
Oseltamivir* / therapeutic use
Platelet Count

Substances

Oseltamivir
Antiviral Agents